These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 32093672

  • 1. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J, Chen B, Wu S, Wu F.
    BMC Pulm Med; 2020 Feb 24; 20(1):50. PubMed ID: 32093672
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
    Gao J, Zhou W, Chen B, Lin W, Wu S, Wu F.
    Int J Chron Obstruct Pulmon Dis; 2017 Feb 24; 12():2703-2710. PubMed ID: 28979112
    [Abstract] [Full Text] [Related]

  • 8. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M, Mycroft K, Paplinska-Goryca M, Górska K, Nejman-Gryz P, Jankowski P, Zak N, Krenke R.
    COPD; 2019 Dec 24; 16(5-6):354-361. PubMed ID: 31631716
    [Abstract] [Full Text] [Related]

  • 9. Post-bronchodilator Reversibility of FEV1 and Eosinophilic Airway Inflammation in COPD.
    Chou KT, Su KC, Hsiao YH, Huang SF, Ko HK, Tseng CM, Su VY, Perng DW.
    Arch Bronconeumol; 2017 Oct 24; 53(10):547-553. PubMed ID: 28438346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
    Zhu J, Mallia P, Footitt J, Qiu Y, Message SD, Kebadze T, Aniscenko J, Barnes PJ, Adcock IM, Kon OM, Johnson M, Contoli M, Stanciu LA, Papi A, Jeffery PK, Johnston SL.
    J Allergy Clin Immunol; 2020 Oct 24; 146(4):840-850.e7. PubMed ID: 32283204
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD.
    Nakamura S, Wakahara K, Majima S, Yokoi E, Fukutani E, Otsuki R, Iwano S, Chen-Yoshikawa TF, Kinoshita F, Abe T, Sashio T, Kimura T, Izuhara K, Hashimoto N, Ishii M, Hasegawa Y.
    BMC Pulm Med; 2024 Oct 13; 24(1):510. PubMed ID: 39396940
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
    Acartürk Tunçay E, Karakurt Z, Aksoy E, Saltürk C, Gungor S, Ciftaslan N, Irmak İ, Yavuz D, Ocakli B, Adıgüzel N.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct 13; 12():3361-3370. PubMed ID: 29200843
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
    Pignatti P, Visca D, Zappa M, Zampogna E, Saderi L, Sotgiu G, Centis R, Migliori GB, Spanevello A.
    BMC Pulm Med; 2024 May 19; 24(1):247. PubMed ID: 38764008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.